Related Experiment Videos
Diagnosing and treating primary pulmonary hypertension.
1Department of Adult Health and Illness, College of Nursing, Ohio State University, Columbus, USA.
The Nurse Practitioner
|October 3, 1999
Summary
Primary pulmonary hypertension (PPH) is a rare lung disease causing high blood pressure in lung arteries. Early diagnosis and new treatments significantly improve patient outcomes and quality of life.
Area of Science:
- Cardiology
- Pulmonology
- Vascular Medicine
Background:
- Primary pulmonary hypertension (PPH) is a severe pulmonary vascular disease.
- It is characterized by elevated mean pulmonary artery pressure and resistance.
- PPH has been linked to appetite suppressants, pregnancy, and certain medical conditions.
Observation:
- Patients often experience dyspnea on exertion and fatigue.
- Early diagnosis is critical for effective management.
- Risk factors include specific drug use (e.g., oral contraceptives, cocaine) and autoimmune disorders.
Findings:
- New therapeutic regimens have shown significant success.
- Treatments halt pulmonary vascular remodeling and prevent right-sided heart failure.
- Effective therapies include calcium channel blockers, anticoagulants, and prostacyclin.
Implications:
- Mortality rates have decreased, and quality of life has improved.
- Medical management offers hope for halting disease progression.
- Lung or heart-lung transplantation is an option for advanced or refractory cases.